Supplementary table 1 B

Sep 23, 2014

10 likes | 92 Views

Supplementary table 1 B.

Share Presentation

Embed Code

Link

supplementary table 1

arav

Download Presentation

Supplementary table 1 B

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplementary table 1 B

Supplementary Table 1

Supplementary Table 1. Patient 1 2 3 4 5 6 7 8 9 10 11. Age (y) 44 36 34 40 26 36 35 48 33 48 35. Sex 1 M M M M F M M F M M M. Disease duration (y) 6 11 4 11 8 7 15 14 8 17 5. Disease classification 2 A2 L1 B3p A2 L1 B3p A2 L3 B3

173 views • 1 slides

Supplementary Table 1

Supplementary Table 1. Supplementary Table 2 The results of screening stage analysis of colorectal cancer .

208 views • 9 slides

Supplementary table 1

Supplementary table 1. Supplementary table 2. Supplementary table 3. A. B. Supplementary table 4. Supplementary table 5. Supplementary table 6. A. B. C. Supplementary Fig. S1. A. B. miR-155. c ontrol. siTRF1. miR-155. c ontrol. siTRF1. -. -. +. +. MG132. -. -. +. +.

249 views • 13 slides

Supplementary Table 1

Supplementary Table 1. A.

165 views • 9 slides

Supplementary table 1.

Supplementary table 1. Strains used in this study. Strain. Genotype. Reference. ho∆ MAT α ::URA3::HOcs hml∆::ADE1 hmr∆::ADE1 ade1-100 leu2-3,112 lys5 trp1::hisG ura3-52 ade3::GAL::HO. SLY19. S. Lee et al. 2003.

100 views • 1 slides

Supplementary Table 1

Supplementary Table 1. A. B. Supplementary Table 2. A. B. Supplementary Fig. 1. Supplementary Table 3.

106 views • 4 slides

Supplementary Table 1:

Supplementary Table 1:.

90 views • 1 slides

Supplementary table 1

Supplementary table 1. Time after trauma (min). MAP (mmHg). ETCO 2 (mmHg). ICP (mmHg). -10. 79 +/- 14. 37.8 +/- 0.9. 3 +/- 1. +10. 72 +/- 11. 37.6 +/- 0.9. +60. 70 +/- 15. 37.8 +/- 0.5. +120. 66 +/- 12. 37.5 +/- 0.9. +180. 59 +/- 12. 37.7 +/- 0.9. 15 +/- 7.

142 views • 5 slides

Supplementary Table 1

Supplementary Table 1. Primers used for qRT-PCR. Supplementary Table 2.

158 views • 3 slides

Supplementary table 1

Supplementary table 1. Gene-expression values of LM f and LDC in microarray analysis were shown.

124 views • 1 slides

Supplementary Table 1.

Supplementary Table 1. Selected reference drugs, testing concentrations and therapeutic exposure.

280 views • 15 slides

Supplementary table 2 B

Supplementary table 2 B.

88 views • 1 slides

Supplementary Table 1: Antibodies

Supplementary Table 1: Antibodies. Supplementary Table 2: Gene specific primer pairs for quantitative real time PCR (qPCR) primers.

269 views • 2 slides

Supplementary Table 1

Supplementary Table 1. A. B. Power et al.

103 views • 1 slides

Supplementary table 1 .

Supplementary table 1. Table 1B. Table 1A. DUSP6 and nuclear P-ERK comparison. DUSP6 and overall P-ERK comparison. Supplementary table 2. Supplementary figure 1. Supplementary figure 2. a. b.

127 views • 4 slides

Supplementary Table 1

Supplementary Table 1 Primers of polymerase chain reaction (PCR) in the corresponding genes tested in Fig. 3. Gene name s. Gene codes. Forward primers (5'>3'). Reverse primers (5'>3'). Length s (bp). Cycles. 24. APS1. A t5g48300. GAAAAACCAAAAGGGGAG. TCAGTCCAAGGGAAGTG. 214. 24.

194 views • 2 slides

Supplementary Information Table 1

Supplementary Information Table 1. Table 1. The classification of human osteosarcoma xenografts response to chemotherapeutic drugs. Abbreviations: TD, Tumor doubling time; SGD, Specific growth delay; T/C%, Maximal growth inhibition. Supplementary Information Table 2.

204 views • 7 slides

Supplementary Table

Antigen. Host. Isotype. Dilution. Source. Ankyrin G. Mouse. IgG1. 1:100. Zymed Labs San Francisco, CA. Caspr. Rabbit. IgG. 1:1000. E. Peles, Israel. Dystrophin. Mouse. IgG1. 1:200. Sigma Missouri, USA. FluoroMyelin green. -. -. 1:400. Molecular Probes Paisley, UK. Kv1.1.

79 views • 1 slides

Supplementary Table 1

Supplementary Table 1. IC50 Value Matrix. Supplementary Table 1: IC 50 value matrix. Each cell line was treated with a dose range of 160 nM up to 1 µM of TAK-733, trametinib or vermurafenib and proliferation was measured using the SRB assay.

163 views • 1 slides

Supplementary Table 1

Supplementary Table 1. Clinical Characteristics of human volunteers. Group I : Normal. Group II : CRS. Supplementary Table 2. Antibodies used for immunofluoresent microscopy. Supplementary Table 3. Antibodies used for mouse flow cytometry.

65 views • 5 slides

Supplementary Table 1

Supplementary Table 1. Supplementary Figure 1. Control. CDAA 4 w. S. S. *. SD. SD.

97 views • 8 slides

Supplementary Table 1

124 views • 11 slides

More Related